How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender

Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System

(2020) Pierpaolo Trimboli et al.   THYROID

Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer:

(2019) R Michael Tuttle et al.   THYROID

Risk for Thyroid Cancer Recurrence Is Higher In Men Than In Women Independent of Disease Stage At Presentation

(2019) Afshan Zahedi et al.   THYROID

An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer

(2016) Iain J. Nixon et al.   THYROID

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

(2016) Bryan R. Haugen et al.   THYROID

Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer

(2014) A. Piccardo et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Focus on High-Risk DTC Patients

(2012) Arnoldo Piccardo et al.   CLINICAL NUCLEAR MEDICINE